JSM 2004 - Toronto

JSM Activity #119

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
119 Mon, 8/9/04, 10:30 AM - 12:20 PM TCC-701 B
Non-inferiority, Superiority, Equivalence, Placebo - Contributed - Papers
Biopharmaceutical Section
Chair(s): Jie Chen, Merck & Co., Inc.
     10:35 AM   Testing Superiority and Noninferiority Hypotheses in Active Controlled Clinical Trails E — Yi Tsong, U.S. Food and Drug Administration; Juan (Joanne) Zhang, U.S. Food and Drug Administration
     10:50 AM   Statistical Analysis of Noninferiority Trials with a Rate Ratio in Small-sample Matched-pair Designs — Ivan S.F. Chan, Merck & Co., Inc.; Nian-Sheng Taug, Center for Applied Statistics; Man-Lai Taug, Harvard Medical School; Ping-Shing Chan, Chinese University of Hong Kong
     11:05 AM   Sample-size Calculations for Noninferiority Clinical Trials Based on Poisson Regression Models — Patrick Darken, ALTANA Pharma U.S.;
     11:20 AM   Choosing the Analysis Population in Noninferiority Studies: Per Protocol or Intent-to-treat — M. Matilde Sanchez, Merck & Co., Inc.; Xun Chen, Merck & Co., Inc.
     11:35 AM   Designing an Optimal Futility Analysis for an Equivalence Trial Using Simulation and Historical Data — Jeff Maca, Novartis Pharmaceuticals
     11:50 AM   Efficacy without a Placebo Group in Mixed Factorial Designs — Charles H. Goldsmith, McMaster University
     12:05 PM   Bias in a Placebo-controlled Study Due to Mismeasurement of Disease Status and Regression Effect — Hung-Mo Lin, Pennsylvania State University; Robert H. Lyles, Emory University; John M. Williamson, Centers for Disease Control and Prevention
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004